International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(9), P. 4640 - 4640
Published: April 28, 2021
Endothelium
has
a
rich
vesicular
network
that
allows
the
exchange
of
macromolecules
between
blood
and
parenchymal
cells.
This
feature
endothelial
cells,
along
with
their
polarized
secretory
machinery,
makes
them
second
major
contributor,
after
platelets,
to
particulate
secretome
in
circulation.
Extracellular
vesicles
(EVs)
produced
by
cells
mirror
remarkable
molecular
heterogeneity
parent
Cargo
molecules
carried
EVs
were
shown
contribute
physiological
functions
endothelium
may
support
plasticity
adaptation
paracrine
manner.
Endothelium-derived
can
also
pathogenesis
cardiovascular
disease
or
serve
as
prognostic
diagnostic
biomarkers.
Finally,
endothelium-derived
be
used
therapeutic
tools
target
for
drug
delivery
stromal
via
In
this
review
we
revisit
recent
evidence
on
EVs.
We
discuss
role
maintenance
vascular
homeostasis
contributions
dysfunction.
evaluate
potential
biomarkers
leverage
tools.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(15)
Published: March 25, 2022
Exosomes
are
extracellular
vesicles
that
share
components
of
their
parent
cells
and
attractive
in
biotechnology
biomedical
research
as
potential
disease
biomarkers
well
therapeutic
agents.
Crucial
to
realizing
this
is
the
ability
manufacture
high-quality
exosomes;
however,
unlike
biologics
such
proteins,
exosomes
lack
standardized
Good
Manufacturing
Practices
for
processing
characterization.
Furthermore,
there
a
well-characterized
reference
exosome
materials
aid
selection
methods
isolation,
purification,
analysis.
This
review
informs
technology
development
by
comparing
characterization
recommending
workflows.
also
provides
detailed
introduction
exosomes,
including
physical
chemical
properties,
roles
normal
biological
processes
progression,
summarizes
some
on-going
clinical
trials.
Theranostics,
Journal Year:
2022,
Volume and Issue:
12(15), P. 6548 - 6575
Published: Jan. 1, 2022
Extracellular
vesicles,
especially
small
extracellular
vesicles
(sEVs)
are
now
accepted
as
important
messengers
in
cell-to-cell
communication
and
a
promising
drug
delivery
platform.They
involved
nearly
all
physiological
pathological
processes
disease
diagnosis
therapy.However,
their
heterogeneity
of
physicochemical
properties
functions
is
not
fully
understood,
which
hinders
further
clinical
applications.To
obtain
highly
bioactive
sEVs
with
both
high
yield
purity,
will
certainly
facilitate
future
study
application.This
review
informs
up-to-date
research
on
frequently-used
cutting-edge
technologies
isolation
makes
deep
comparison
analysis
different
methods,
including
advantages,
limitations
applications.Pending
questions
about
the
inherent
property
these
well
strategies
discussed.Additionally,
an
overview
applications
treatment,
some
on-going
trials,
also
reviewed.
Food and Chemical Toxicology,
Journal Year:
2022,
Volume and Issue:
164, P. 113008 - 113008
Published: April 15, 2022
The
mRNA
SARS-CoV-2
vaccines
were
brought
to
market
in
response
the
public
health
crises
of
Covid-19.
utilization
context
infectious
disease
has
no
precedent.
many
alterations
vaccine
hide
from
cellular
defenses
and
promote
a
longer
biological
half-life
high
production
spike
protein.
However,
immune
is
very
different
that
infection.
In
this
paper,
we
present
evidence
vaccination
induces
profound
impairment
type
I
interferon
signaling,
which
diverse
adverse
consequences
human
health.
Immune
cells
have
taken
up
nanoparticles
release
into
circulation
large
numbers
exosomes
containing
protein
along
with
critical
microRNAs
induce
signaling
recipient
at
distant
sites.
We
also
identify
potential
disturbances
regulatory
control
synthesis
cancer
surveillance.
These
potentially
causal
link
neurodegenerative
disease,
myocarditis,
thrombocytopenia,
Bell's
palsy,
liver
impaired
adaptive
immunity,
DNA
damage
tumorigenesis.
show
VAERS
database
supporting
our
hypothesis.
believe
comprehensive
risk/benefit
assessment
questions
them
as
positive
contributors
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Jan. 21, 2023
Despite
advances
in
early
detection
and
therapies,
cancer
is
still
one
of
the
most
common
causes
death
worldwide.
Since
each
tumor
unique,
there
a
need
to
implement
personalized
care
develop
robust
tools
for
monitoring
treatment
response
assess
drug
efficacy
prevent
disease
relapse.
Journal of Translational Medicine,
Journal Year:
2022,
Volume and Issue:
20(1)
Published: Jan. 3, 2022
Exosomal
miRNAs
have
attracted
much
attention
due
to
their
critical
role
in
regulating
genes
and
the
altered
expression
of
virtually
all
cancers
affecting
humans
(Sun
et
al.
Mol
Cancer
17(1):14,
2018).
modulate
processes
that
interfere
with
cancer
immunity
microenvironment,
are
significantly
involved
tumor
growth,
invasion,
metastasis,
angiogenesis
drug
resistance.
Fully
investigating
detailed
mechanism
occurrence
development
various
could
help
not
only
treatment
but
also
prevention
malignant
diseases.
The
current
review
highlighted
recently
published
advances
regarding
cancer-derived
exosomes,
e.g.,
sorting
delivery
mechanisms
for
RNAs.
cell-to-cell
communication,
impacting
angiogenesis,
metastasis
multiple
biological
features,
were
discussed.
Finally,
potential
exosomal
as
diagnostic
prognostic
molecular
markers
was
summarized,
well
usefulness
detecting
resistance
therapeutic
agents.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(8), P. 2042 - 2042
Published: July 29, 2023
Exosome-based
drug
delivery
is
emerging
as
a
promising
field
with
the
potential
to
revolutionize
therapeutic
interventions.
Exosomes,
which
are
small
extracellular
vesicles
released
by
various
cell
types,
have
attracted
significant
attention
due
their
unique
properties
and
natural
ability
transport
bioactive
molecules.
These
nano-sized
vesicles,
ranging
in
size
from
30
150
nm,
can
effectively
variety
of
cargoes,
including
proteins,
nucleic
acids,
lipids.
Compared
traditional
systems,
exosomes
exhibit
biocompatibility,
low
immunogenicity,
reduced
toxicity.
In
addition,
be
designed
tailored
improve
targeting
efficiency,
cargo
loading
capacity,
stability,
paving
way
for
personalized
medicine
precision
therapy.
However,
despite
exosome-based
delivery,
its
clinical
application
remains
challenging
limitations
exosome
isolation
purification,
efficiency
insufficient
targeted
rapid
elimination
circulation.
This
comprehensive
review
focuses
on
transition
bench
clinic,
highlighting
key
aspects,
such
structure
biogenesis,
methods,
surface
engineering
techniques,
applications.
It
also
discusses
challenges
prospects
this
field.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: June 10, 2022
Periodontitis
is
an
infectious
oral
disease,
which
leads
to
the
destruction
of
periodontal
tissues
and
tooth
loss.
Although
treatment
periodontitis
has
improved
recently,
effective
periodontitis-affected
still
a
challenge.
Therefore,
it
urgent
explore
new
therapeutic
strategies
for
periodontitis.
Natural
products
show
anti-microbial,
anti-inflammatory,
anti-oxidant
bone
protective
effects
most
these
natural
are
safe
cost-effective.
Among
these,
plant-derived
exosome-like
nanoparticles
(PELNs),
type
nanocarriers
repleted
with
lipids,
proteins,
RNAs,
other
active
molecules,
ability
enter
mammalian
cells
regulate
cellular
activities.
Reports
from
literature
indicate
great
potential
PELNs
in
regulation
immune
functions,
inflammation,
microbiome,
tissue
regeneration.
Moreover,
can
also
be
used
as
drug
carriers
enhance
stability
uptake
vivo.
Since
function,
regeneration
key
phenomena
usually
targeted
during
treatment,
hold
promising
treatment.
This
review
summarizes
recent
advances
PELNs-related
research
that
related
periodontitis-destructed
underlying
mechanisms.
We
discuss
existing
challenges
prospects
application
PELNs-based
approaches
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: April 13, 2023
Abstract
Extracellular
vesicles
have
shown
good
potential
in
disease
treatments
including
ischemic
injury
such
as
myocardial
infarction.
However,
the
efficient
production
of
highly
active
extracellular
is
one
critical
limitations
for
their
clinical
applications.
Here,
we
demonstrate
a
biomaterial-based
approach
to
prepare
high
amounts
with
bioactivity
from
endothelial
progenitor
cells
(EPCs)
by
stimulation
silicate
ions
derived
bioactive
ceramics.
We
further
show
that
hydrogel
microspheres
containing
engineered
are
effective
treatment
infarction
male
mice
significantly
enhancing
angiogenesis.
This
therapeutic
effect
attributed
enhanced
revascularization
content
miR-126a-3p
and
angiogenic
factors
VEGF
SDF-1,
CXCR4
eNOS
vesicles,
which
not
only
activate
but
also
recruit
EPCs
circulatory
system.